Weight loss method for people with overweight or obesity in primary care
Official title: Placebo-Controlled, Randomized Weight Loss InterventionTrial in Subjects With Overweight or Obesity in Primary Health Care
Run by Vastra Gotaland Region · NCT04184479 · Data updated 2026-11-12
This study tests a new weight loss method called LEVA to see if it can help people with overweight or obesity in primary care lose weight and keep it off.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Vastra Gotaland Region Government |
| Locations | 1 site (Gothenburg) |
| Status | Recruiting |
| Started | December 2, 2020 |
| Main results expected | August 2026 |
| Study ends | August 2027 |
| Registry record updated | November 25, 2024 |
| Trial ID | NCT04184479 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18-75 with a BMI between 27 and 35.
✕Probably not a fit
Patients who have difficulty understanding Swedish or are unwilling to use digital tools may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of the LEVA method by Bertz et al, which is designed to promote sustainable weight loss in individuals with overweight or obesity. The trial focuses on patients referred to primary health care centers in Västra Götalandsregionen. By assessing the method's impact beyond postpartum women, the study aims to determine its broader applicability for weight management in various patient groups. Participants will engage with digital tools as part of the intervention to facilitate their weight loss journey.
Why it matters
Potential benefit: If successful, this method could provide a new, effective treatment option for individuals struggling with overweight and obesity.
How similar studies have gone: While the LEVA method has been previously studied for postpartum women, its application to a broader population is relatively novel and untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * BMI 27 ≤ 35 * age 18-75 år Exclusion Criteria: * difficulty understanding Swedish, spoken or read * does not manage/want to handle digital Tools * the remittance was addressed to Primärvårdens Dietistenhet at wrong premises and the patient should be treated elsewhere.
Where it's running
-
Västra Götalandsregionen
Gothenburg, Sweden Recruiting
Study contacts
- Principal investigator: Else Johansson — Västra Götalandsregionen
- Study coordinator: Else Johansson
- Email: else.hellebo.johansson@vgregion.se
- Phone: +46768871219
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nutrition support to improve dietary diversity in adults who are underweight or overweight/obese
A community-based nutrition program will be tested in adults in Cambodia to see if it improves dietary diversity and if the program is acceptable and feasible to run.
-
Hesperidin for better thinking in overweight older adults
In adults aged 55–75 who are overweight, taking hesperidin or a placebo for 10 weeks will show whether the citrus flavonoid can improve thinking skills like memory, attention, and problem-solving.
-
MR-based performance tests for overweight and obesity
This study tests mixed reality versions of mobility tests to see if they match conventional assessments in adults who are overweight or obese.
-
DA-302168S in adults with overweight or obesity
A phase 3 trial in China is testing whether DA-302168S helps people who are overweight or obese lose weight compared with a placebo.
-
Metabolic Health Trajectories in Overweight Chinese Adults
This observational study follows overweight and obese Chinese adults to see how metabolic health changes over five years and whether people stay healthy, develop diabetes, or have complications.
-
Blood-count inflammation scores (SII and SIRI) to predict metabolic complications in adults with overweight or obesity
This project will test whether two blood-count-based scores (SII and SIRI) can help predict metabolic complications and treatment response in adults with overweight or obesity.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.